经膀胱前列腺剜出开放手术与经尿道前列腺等离子电切术治疗良性前列腺增生症的价值比较
|
摘要
目的评估经尿道前列腺等离子电切术运用在良性前列腺增生症患者治疗中的临床价值。方法对该医院开展手术治疗的100例良性前列腺增生症患者予以项目研究,将2016年3月—2018年11月作为实验组选择时间,试验组采用经尿道前列腺等离子电切术治疗,对照组随机选择2000—2010年间采用传统经膀胱前列腺剜出开放手术治疗患者30例,对比两组临床治疗有效统计率、手术耗时、术中出血量、术后拔尿管天数、住院天数、术后并发症统计率,且分析两组术前和术后最大尿流率、膀胱残余尿量。结果试验组临床治疗有效统计率较97.14%对照组对应数据指标(76.67%)提升,展现数据间差异有统计学意义(χ~2=10.750,P=0.001<0.05);试验组手术耗时(53.60±4.54)min较对照组对应数据指标(44.63±5.80)min提升,试验组术中出血量(33.61±3.60)m L、术后拔尿管天数(4.90±1.21)d、住院天数(8.12±1.30)d较对照组对应数据指标[(103.40±6.87)mL、(7.31±2.10)d、(12.60±2.31)d]下降,展现数据间差异有统计学意义(t=8.310、66.554、7.226、12.337,P=0.000、0.000、0.000、0.000<0.05);试验组术后并发症统计率2.86%较对照组对应数据指标(20.00%)下降,展现数据间差异有统计学意义(χ~2=8.385,P=0.003<0.05);试验组最大尿流率(14.70±3.12)mL/s较对照组对应数据指标(11.63±2.10)m L/s提升,试验组膀胱残余尿量(13.80±1.23)mL较对照组对应数据指标(27.15±2.30)mL下降,展现数据间差异有统计学意义(t=4.925、37.919,P=0.000、0.000<0.05)。结论对良性前列腺增生症患者实行经尿道前列腺等离子电切术治疗获得较优临床疗效,表明临床推广应用优势。
Objective To evaluate the clinical value of transurethral resection of prostate in patients with benign prostatic hyperplasia.Methods 100 patients with benign prostatic hyperplasia who underwent surgery in our hospital were selected for the study. The pa-tients from March 2016 to November 2018 were selected as the experimental group. The experimental group was treated with transurethral resection of the prostate. 30 patients who underwent open surgery with conventional transurethral resection of the prostate from 2000 to 2010 were randomly selected as the control group. The effective statistical rate, time-consuming operation, in-traoperative blood loss, postoperative urinary catheterization days, hospitalization days, and postoperative time were compared between the two groups. The statistic rate of complications was analyzed, and the maximum urinary flow rate before and after surgery and the residual urine volume of the bladder were analyzed. Results The effective statistical rate of clinical treatment in the experimental group 97.14% was higher than that of the control group(76.67%), showing statistically significant statistical significance( χ~2=10.750,P=0.001<0.05); the experimental group was time-consuming(53.60±4.54)min, compared with the control group, the corresponding data index(44.63 ±5.80)min was improved. The intraoperative blood loss(33.61 ±3.60)mL, postoperative urinary catheterization time(4.90±1.21)d, and hospitalization days(8.12±1.30)d were compared with the control group of [(103.40±6.87)mL,(7.31±2.10)d,(12.60±2.31)d] decreased, showing significant statistical significance(t=8.310, 66.554, 7.226, 12.337,P =0.000, 0.000, 0.000, 0.000 <0.05);The statistical rate of postoperative complications was 2.86% in the experimental group compared with the control group(20.00%) decreased, showing significant statistical significance between the data(χ~2=8.385,P=0.003<0.05); the maximum urinary flow rate(14.70±3.12)mL/s in the experimental group was higher than that in the control group(11.63 ±2.10)mL/s, and the experimental group was bladder. The residual urine volume(13.80±1.23)mL was lower than that of the control group(27.15±2.30)mL, showing significant statistical significance(t=4.925, 37.919, P=0.000, 0.000<0.05). Conclusion Transurethral resection of prostate in patients with benign prostatic hyperplasia has achieved superior clinical efficacy, indicating the advantages of clinical application.
Objective To evaluate the clinical value of transurethral resection of prostate in patients with benign prostatic hyperplasia.Methods 100 patients with benign prostatic hyperplasia who underwent surgery in our hospital were selected for the study. The pa-tients from March 2016 to November 2018 were selected as the experimental group. The experimental group was treated with transurethral resection of the prostate. 30 patients who underwent open surgery with conventional transurethral resection of the prostate from 2000 to 2010 were randomly selected as the control group. The effective statistical rate, time-consuming operation, in-traoperative blood loss, postoperative urinary catheterization days, hospitalization days, and postoperative time were compared between the two groups. The statistic rate of complications was analyzed, and the maximum urinary flow rate before and after surgery and the residual urine volume of the bladder were analyzed. Results The effective statistical rate of clinical treatment in the experimental group 97.14% was higher than that of the control group(76.67%), showing statistically significant statistical significance( χ~2=10.750,P=0.001<0.05); the experimental group was time-consuming(53.60±4.54)min, compared with the control group, the corresponding data index(44.63 ±5.80)min was improved. The intraoperative blood loss(33.61 ±3.60)mL, postoperative urinary catheterization time(4.90±1.21)d, and hospitalization days(8.12±1.30)d were compared with the control group of [(103.40±6.87)mL,(7.31±2.10)d,(12.60±2.31)d] decreased, showing significant statistical significance(t=8.310, 66.554, 7.226, 12.337,P =0.000, 0.000, 0.000, 0.000 <0.05);The statistical rate of postoperative complications was 2.86% in the experimental group compared with the control group(20.00%) decreased, showing significant statistical significance between the data(χ~2=8.385,P=0.003<0.05); the maximum urinary flow rate(14.70±3.12)mL/s in the experimental group was higher than that in the control group(11.63 ±2.10)mL/s, and the experimental group was bladder. The residual urine volume(13.80±1.23)mL was lower than that of the control group(27.15±2.30)mL, showing significant statistical significance(t=4.925, 37.919, P=0.000, 0.000<0.05). Conclusion Transurethral resection of prostate in patients with benign prostatic hyperplasia has achieved superior clinical efficacy, indicating the advantages of clinical application.
引文
[1]向宸辉,王鹏桥,陈胜龙,等.前列腺剜除术与电切术治疗前列腺增生症的临床研究[J].西南国防医药,2017,27(9):952-955.
[2]周亚,林长丰,李永,等.经尿道前列腺等离子双极电切治疗良性前列腺增生症[J].河北医药,2016,38(10):1533-1534,1537.
[3]郝炜,云志中,马可为,等.双极等离子前列腺剜除术与电切术治疗前列腺增生症的随机对照研究[J].临床和实验医学杂志,2017,16(4):388-390.
[4]何斌,唐庆生,倪浩东,等.经尿道等离子前列腺电切结合部分剜除法治疗大体积前列腺增生症疗效分析[J].实用临床医药杂志,2017,21(24):86-87.
[5]俞敏,曾庆春,杨敏,等.经尿道等离子电切前列腺剜除术治疗良性前列腺增生症的临床分析[J].微创医学,2016,11(6):943-944,939.
[6]罗成军,李静文.经尿道等离子前列腺剜除术治疗前列腺增生症的疗效分析[J].中华老年多器官疾病杂志,2016,15(8):617-620.
[7]李超.经尿道前列腺电切术治疗良性前列腺增生症的临床分析[J].中外医疗,2016,35(18):32-33,38.
[8]马海,李杨,周文奇,等.经尿道双极等离子腔内前列腺剜除术治疗前列腺增生症(附360例报告)[J].中国微创外科杂志,2016,16(6):495-497.
[9]彭涛,庄红雨,许学敏,等.良性前列腺增生症患者经尿道前列腺电切术后服用非那雄胺的临床效果及病症影响因素[J].中国医药,2017,12(11):1735-1739.
[10]何宗海,官润云,杨旷平,等.经尿道前列腺等离子电切术与2μm铥激光汽化切除术治疗良性前列腺增生症的并发症对比[J].广东医学,2017,38(14):2202-2205.
[2]周亚,林长丰,李永,等.经尿道前列腺等离子双极电切治疗良性前列腺增生症[J].河北医药,2016,38(10):1533-1534,1537.
[3]郝炜,云志中,马可为,等.双极等离子前列腺剜除术与电切术治疗前列腺增生症的随机对照研究[J].临床和实验医学杂志,2017,16(4):388-390.
[4]何斌,唐庆生,倪浩东,等.经尿道等离子前列腺电切结合部分剜除法治疗大体积前列腺增生症疗效分析[J].实用临床医药杂志,2017,21(24):86-87.
[5]俞敏,曾庆春,杨敏,等.经尿道等离子电切前列腺剜除术治疗良性前列腺增生症的临床分析[J].微创医学,2016,11(6):943-944,939.
[6]罗成军,李静文.经尿道等离子前列腺剜除术治疗前列腺增生症的疗效分析[J].中华老年多器官疾病杂志,2016,15(8):617-620.
[7]李超.经尿道前列腺电切术治疗良性前列腺增生症的临床分析[J].中外医疗,2016,35(18):32-33,38.
[8]马海,李杨,周文奇,等.经尿道双极等离子腔内前列腺剜除术治疗前列腺增生症(附360例报告)[J].中国微创外科杂志,2016,16(6):495-497.
[9]彭涛,庄红雨,许学敏,等.良性前列腺增生症患者经尿道前列腺电切术后服用非那雄胺的临床效果及病症影响因素[J].中国医药,2017,12(11):1735-1739.
[10]何宗海,官润云,杨旷平,等.经尿道前列腺等离子电切术与2μm铥激光汽化切除术治疗良性前列腺增生症的并发症对比[J].广东医学,2017,38(14):2202-2205.